3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Other hematologic neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Neoplasms
1
Hematologic Neoplasms
1
Cardiovascular Diseases
1
Interventions
venetoclax
157
Cytarabine
117
Cyclophosphamide
110
Specimen Handling
103
Azacitidine
103
fludarabine
89
Biopsy
78
Rituximab
50
Methotrexate
45
Daunorubicin
45
fludarabine phosphate
41
Vincristine
38
Dexamethasone
37
Injections
36
Magnetic Resonance Spectroscopy
35
Decitabine
35
Granulocyte Colony-Stimulating Factor
32
blinatumomab
31
Mycophenolic Acid
30
Idarubicin
30
Whole-Body Irradiation
29
ibrutinib
27
Tacrolimus
27
Prednisone
27
Etoposide
27
Doxorubicin
27
Busulfan
27
acalabrutinib
24
Melphalan
24
Filgrastim
24
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Antineoplastic Agents
×
Other hematologic neoplasm
×
90 days
×
Clear all
NCT07621289
2026-06-02
EUCARTOXSCORES
University Hospital, Caen
Not yet recruiting
10,000 enrolled